Patents by Inventor Matthew C. Mendel

Matthew C. Mendel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230392118
    Abstract: Provided herein are improved methods and compositions for generating CD4-positive effector T cells and regulatory T cells and methods of use thereof.
    Type: Application
    Filed: October 28, 2021
    Publication date: December 7, 2023
    Applicant: Sangamo Therapeutics, Inc.
    Inventors: Helen Fong, Anthony Conway, Matthew C. Mendel
  • Publication number: 20220395556
    Abstract: Disclosed herein are methods and compositions for modulating expression of a PD1 gene.
    Type: Application
    Filed: January 28, 2022
    Publication date: December 15, 2022
    Inventors: Philip D. Gregory, Michael C. Holmes, Matthew C. Mendel, Xiangdong Meng, David Paschon, Andreas Reik, Fyodor Urnov
  • Patent number: 11235026
    Abstract: Disclosed herein are methods and compositions for modulating expression of a PD1 gene.
    Type: Grant
    Filed: July 12, 2018
    Date of Patent: February 1, 2022
    Assignee: Sangamo Therapeutics, Inc.
    Inventors: Philip D. Gregory, Michael C. Holmes, Matthew C. Mendel, Xiangdong Meng, David Paschon, Andreas Reik, Fyodor Urnov
  • Publication number: 20180326000
    Abstract: Disclosed herein are methods and compositions for modulating expression of a PD1 gene.
    Type: Application
    Filed: July 12, 2018
    Publication date: November 15, 2018
    Inventors: Philip D. Gregory, Michael C. Holmes, Matthew C. Mendel, Xiangdong Meng, David Paschon, Andreas Reik, Fyodor Urnov
  • Patent number: 10046028
    Abstract: Disclosed herein are methods and compositions for modulating expression of a PD1 gene.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: August 14, 2018
    Assignee: Sangamo Therapeutics, Inc.
    Inventors: Philip D. Gregory, Michael C. Holmes, Matthew C. Mendel, Xiangdong Meng, David Paschon, Andreas Reik, Fyodor Urnov
  • Publication number: 20160220634
    Abstract: Disclosed herein are methods and compositions for modulating expression of a PD1 gene.
    Type: Application
    Filed: April 20, 2016
    Publication date: August 4, 2016
    Inventors: Philip D. Gregory, Michael C. Holmes, Matthew C. Mendel, Xiangdong Meng, David Paschon, Andreas Reik, Fyodor Urnov
  • Patent number: 9402879
    Abstract: Disclosed herein are methods and compositions for modulating expression of a PD1 gene.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: August 2, 2016
    Assignee: Sangamo BioSciences, Inc.
    Inventors: Philip D. Gregory, Michael C Holmes, Matthew C. Mendel, Xiangdong Meng, David Paschon, Andreas Reik, Fyodor Urnov
  • Publication number: 20140030240
    Abstract: Disclosed herein are methods and compositions for modulating expression of a PD1 gene.
    Type: Application
    Filed: September 27, 2013
    Publication date: January 30, 2014
    Applicant: Sangamo BioSciences, Inc.
    Inventors: Philip D. Gregory, Michael C. Holmes, Matthew C. Mendel, Xiangdong Meng, David Paschon, Andreas Reik, Fyodor Urnov
  • Patent number: 8563314
    Abstract: Disclosed herein are methods and compositions for modulating expression of a PD1 gene.
    Type: Grant
    Filed: November 17, 2010
    Date of Patent: October 22, 2013
    Assignee: Sangamo BioSciences, Inc.
    Inventors: Philip D. Gregory, Michael C. Holmes, Matthew C. Mendel, Xiangdong Meng, David Paschon, Andreas Reik, Fyodor Urnov
  • Publication number: 20110136895
    Abstract: Disclosed herein are methods and compositions for modulating expression of a PD1 gene.
    Type: Application
    Filed: November 17, 2010
    Publication date: June 9, 2011
    Inventors: Philip D. Gregory, Michael C. Holmes, Matthew C. Mendel, Xiangdong Meng, David Paschon, Andreas Reik, Fyodor Urnov